You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》心通醫療(02160.HK)暗盤高開64%報20元
阿思達克 02-03 16:16
根據輝立交易平台顯示,明天掛牌的微創心通醫療科技-B(02160.HK)暗盤高開64%報20元獲承接,最高見21.15元,現造19.5元,較上市價12.2元,高61%;成交523萬股。

微創心通由微創醫療(00853.HK)分拆上市,公司專注於心臟瓣膜疾病領域創新的經導管及手術解決方案的研發和商業化。是次上市共發售2.06億股,並已包括源峰基金、Hillhouse Funds、GIC、雪湖資本及華夏基金等16名基石投資者,合共認購7,943.3萬股;其中10%公開發售獲768倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率僅7.5%;股份以招股範圍(11.1-12.2元)上限定價,料集資淨額約23.56億元,主要用作核心產品VitaFlow II、用於微創心通首款商業化TAVI產品VitaFlow、用作現有產品管線的其他產品、透過併購和授權引進安排或股權投資與包括醫療器械企業及研究機構在內全球賦能者合作擴展集團產品組合提供資金、擴大產能並提高生產VitaFlow及VitaFlow II能力等。上市聯席保薦人分別為大摩、花旗及中金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account